- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01733212
Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients
Efficacy of Ginger on Intraoperative and Postoperative Nausea and Vomiting in Elective Cesarean Section Patients.
SPECIFIC AIMS
- Assess risk factors for nausea and vomiting in c-section patients undergoing regional anesthesia
- Quantify the incidence of nausea and vomiting intraoperatively and postoperatively in the ginger and placebo groups.
- Quantify post-operative analgesia and pruritus in the ginger and placebo groups
- Quantify patient satisfaction of the ginger and placebo groups
- Assess patient expectation of ginger on post-op day three
Study Overview
Status
Intervention / Treatment
Detailed Description
Two hundred and thirty nine ASA class I and II patients, scheduled for elective c-section will be assigned randomly to receive either 1g ginger tablet PO (Group 1) or 1 g placebo PO (Group 2) preoperatively, immediately before surgery. The usual preoperative anti-emetic and antacid regimen will be continued for both groups. Initial blood pressure, pulse and hemoglobin and hematocrit will be documented by the researcher prior to the arrival of the patient into the operating room. A baseline questionnaire will be given to the patients to assess risk factors for nausea and vomiting. Questions will include: age, BMI, parity, weeks gestation, h/o seasickness, h/o of hyperemesis gravidrum in this or prior pregnancies, h/o PONV, medical problems, any medication used within past 24 hrs, education and occupation.
Intraoperatively, both groups will receive combined spinal-epidural anesthesia in the usual manner. All standard monitoring will be applied and vital signs recorded for the entirety of the procedure. The number and dose of ephedrine or phenylephrine boluses and the number and severity of nausea episodes (using a Visual Analog Scale (VANS)) and number of vomiting episodes will be noted. In addition the following will be recorded: if uterus was exteriorized, any medications used by the anesthesiologist (other than ephedrine and phenylephrine), and estimated blood loss.
Postoperatively, patients will receive either a one time dose of the 1g ginger PO (Group 1) or 1 g placebo PO (Group 2) 2 hours after entering the postanesthesia care unit (PACU). Thirty minutes after the medication is given, patients will be asked to rate their nausea, level of analgesia, and level of pruritus on a VANS, and vomiting episodes will be recorded. Medications given for nausea will be continued in the post-operative period for both groups. The doses of Zofran will be counted in the 24 hr postoperative period. Twenty-four hours after surgery, blood will be drawn to assess hemoglobin and hematocrit as well as to assess platelet function.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
New York
-
Brooklyn, New York, United States, 11215
- New York Methodist Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy (i.e., ASA I, or II) patients presenting for planned c-section at New York Methodist Hospital
- Signed informed consent
Exclusion Criteria:
- They are unable or unwilling to take part in the study
- They have a history of an allergy to any medications used including ginger
- They have had any gastrointestinal surgery on the stomach, small intestine, or gall bladder.
- They have any history of bleeding disorder, (i.e., Hemophilia A/B, ITP, etc.)
- They have a contraindication to intrathecal or epidural anesthesia. ( i.e., Arnold- Chiari malformation, etc.)
- They are unable to understand instructions or questions related to study
- ASA III or IV patients
Study Plan
How is the study designed?
Design Details
- Primary Purpose: PREVENTION
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: QUADRUPLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Ginger
2 gm powder of ginger filled in a capsule
|
Ginger is an herb.
The rhizome (underground stem) is used as a spice and also as a medicine.
It can be used fresh, dried and powdered, or as a juice or oil.
Two capsules (1g each) of dry powdered ginger are given, one capsule a half-hour before induction of anesthesia and the second 2h after surgery.
Other Names:
|
PLACEBO_COMPARATOR: Placebo
2 gm of placebo pill (A capsule)
|
Two capsules (1g each) of placebo, one capsule a half-hour before induction of anesthesia and the second 2h after surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Occurrence of Intra-operative and Post-operative Vomiting
Time Frame: During surgery (1 hour) and thru 72 hours after surgery
|
Participants who had intra-operative and post-operative vomiting were identified and compared between the two groups.
|
During surgery (1 hour) and thru 72 hours after surgery
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Jonathan Weinberg, MD, New York Presbyterian Brooklyn Methodist Hospital
Publications and helpful links
General Publications
- Griffiths JD, Gyte GM, Popham PA, Williams K, Paranjothy S, Broughton HK, Brown HC, Thomas J. Interventions for preventing nausea and vomiting in women undergoing regional anaesthesia for caesarean section. Cochrane Database Syst Rev. 2021 May 18;5(5):CD007579. doi: 10.1002/14651858.CD007579.pub3.
- Kalava A, Darji SJ, Kalstein A, Yarmush JM, SchianodiCola J, Weinberg J. Efficacy of ginger on intraoperative and postoperative nausea and vomiting in elective cesarean section patients. Eur J Obstet Gynecol Reprod Biol. 2013 Jul;169(2):184-8. doi: 10.1016/j.ejogrb.2013.02.014. Epub 2013 Mar 17.
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB:147810
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Nausea
-
University of North Carolina, Chapel HillNational Institute of Dental and Craniofacial Research (NIDCR)CompletedPost-operative Nausea | Post-operative Vomiting | Nausea PersistentUnited States
-
Cukurova UniversityTarsus UniversityRecruitingNausea, Postoperative | Vomiting, Postoperative | APFEL RİSK SCORETurkey
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
-
Hoffmann-La RocheCompletedPost-Operative Nausea and VomitingUnited States
-
Cairo UniversityUnknownPost Operative Nausea and VomitingEgypt
-
Yonsei UniversityCompletedPost Operative Nausea and VomitingKorea, Republic of
-
Lancaster General HospitalCompletedBariatric Surgery Candidate | Nausea, PostoperativeUnited States
-
AccentureCompletedPost-Operative Nausea and Vomiting (PONV)Australia
-
Mayo ClinicCompleted
Clinical Trials on Ginger
-
Emily DiMango, MDNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Georgetown UniversityCompletedDiabetes MellitusUnited States
-
Loma Linda UniversityCompletedHealthyUnited States
-
The University of The West IndiesCompletedPostoperative Nausea and VomitingJamaica
-
Gary MorrowNational Cancer Institute (NCI)CompletedNausea | VomitingUnited States
-
National Center for Complementary and Integrative...CompletedNausea | Vomiting | ChemotherapyUnited States, Puerto Rico
-
University of New MexicoCompletedLichen Planus | Lichen Planopilaris | Lichen Planus ScalpUnited States
-
Mahidol UniversityCompletedChemotherapy-induced Nausea and VomitingThailand
-
Federico II UniversityCompletedNausea | VomitingItaly
-
ARCIM Institute Academic Research in Complementary...Completed